RXO, Inc. (RXO) Income Statement
RXO 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsRXO revenue and net income
Where RXO's revenue goes
2025Each bar shows an amount and its share of revenue. RXO kept −1.7% of revenue as net income.
RXO profit margins
RXO growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +26.2% | +6.2% | +11.3% | — |
| Gross profit | +18.5% | −1.4% | +8.9% | — |
| Operating income | −123.3% | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | −600.0% | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
RXO quarterly EPS vs estimates
RXO beat the analyst EPS estimate in 5 of the last 8 quarters. Next report: November 5, 2026 (estimate $0.08).
RXO income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $5.74B | $4.55B | $3.93B | $4.80B | $4.69B | $3.36B | $3.14B |
| Cost of revenue | $4.92B | $3.85B | $3.27B | $3.94B | $3.95B | $2.82B | $2.65B |
| Gross profit | $825.0M | $696.0M | $658.0M | $860.0M | $735.0M | $539.0M | $491.0M |
| Sales, general & admin | $832.0M | $666.0M | $591.0M | $84.0M | $541.0M | $469.0M | $400.0M |
| Total operating expenses | $832.0M | $666.0M | $591.0M | $640.0M | $543.0M | $479.0M | $409.0M |
| Operating income | −$7.0M | $30.0M | $67.0M | $220.0M | $192.0M | $60.0M | $82.0M |
| Interest income | $35.0M | $30.0M | $32.0M | $4.0M | — | — | — |
| Interest expense | $35.0M | $30.0M | $32.0M | $4.0M | $5.0M | $23.0M | $16.0M |
| Income before taxes | −$115.0M | −$304.0M | $4.0M | $119.0M | $191.0M | $57.0M | $84.0M |
| Income taxes | −$15.0M | −$14.0M | $29.0M | $27.0M | $41.0M | $14.0M | $22.0M |
| Net income | −$100.0M | −$290.0M | $4.0M | $92.0M | $150.0M | $43.0M | $62.0M |
| EBITDA | $36.0M | −$187.0M | $103.0M | $209.0M | $272.0M | $133.0M | $166.0M |
| EPS (diluted) | −$0.05 | $0.01 | $0.30 | $0.73 | $1.30 | $0.37 | — |
| Gross margin | 14.4% | 15.3% | 16.8% | 17.9% | 15.7% | 16.1% | 15.6% |
| Operating margin | −0.1% | 0.7% | 1.7% | 4.6% | 4.1% | 1.8% | 2.6% |
| Net margin | −1.7% | −6.4% | 0.1% | 1.9% | 3.2% | 1.3% | 2.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.77B | $1.43B | $1.47B | $1.42B | $1.42B | $1.43B | $1.67B | $1.04B | $930.0M | $913.0M | $978.0M | $976.0M |
| Cost of revenue | $1.52B | $1.25B | $1.28B | $1.21B | $1.20B | $1.20B | $1.41B | $858.0M | $767.0M | $768.0M | $799.0M | $801.0M |
| Gross profit | $249.0M | $178.0M | $191.0M | $210.0M | $224.0M | $232.0M | $260.0M | $182.0M | $163.0M | $145.0M | $179.0M | $175.0M |
| Sales, general & admin | $211.0M | $197.0M | $200.0M | $208.0M | $214.0M | $210.0M | $218.0M | $149.0M | $154.0M | $145.0M | $443.0M | $148.0M |
| Total operating expenses | $248.0M | $197.0M | $200.0M | $208.0M | $214.0M | $262.0M | $284.0M | $202.0M | $154.0M | $157.0M | $165.0M | $169.0M |
| Operating income | $1.0M | −$19.0M | −$9.0M | $2.0M | $10.0M | −$30.0M | −$24.0M | −$20.0M | $9.0M | −$12.0M | $14.0M | $6.0M |
| Interest income | — | — | $9.0M | $9.0M | $8.0M | $9.0M | $8.0M | $6.0M | — | — | — | $8.0M |
| Interest expense | $9.0M | $9.0M | $9.0M | $9.0M | $8.0M | $9.0M | $8.0M | $6.0M | $8.0M | $8.0M | $8.0M | $8.0M |
| Income before taxes | −$8.0M | −$49.0M | −$51.0M | −$15.0M | −$10.0M | −$39.0M | −$33.0M | −$242.0M | −$8.0M | −$21.0M | $4.0M | −$3.0M |
| Income taxes | $1.0M | −$13.0M | −$5.0M | −$1.0M | −$1.0M | −$8.0M | −$8.0M | $1.0M | −$1.0M | −$6.0M | $2.0M | −$2.0M |
| Net income | −$9.0M | −$36.0M | −$46.0M | −$14.0M | −$9.0M | −$31.0M | −$25.0M | −$243.0M | −$7.0M | −$15.0M | $2.0M | −$1.0M |
| EBITDA | $27.0M | −$14.0M | −$14.0M | $20.0M | $28.0M | $22.0M | $42.0M | $33.0M | $17.0M | $3.0M | $33.0M | $27.0M |
| EPS (diluted) | $0.06 | −$0.09 | −$0.07 | $0.01 | $0.04 | −$0.03 | $0.06 | $0.05 | $0.03 | −$0.13 | $0.06 | $0.05 |
| Gross margin | 14.0% | 12.5% | 13.0% | 14.8% | 15.8% | 16.2% | 15.6% | 17.5% | 17.5% | 15.9% | 18.3% | 17.9% |
| Operating margin | 0.1% | −1.3% | −0.6% | 0.1% | 0.7% | −2.1% | −1.4% | −1.9% | 1.0% | −1.3% | 1.4% | 0.6% |
| Net margin | −0.5% | −2.5% | −3.1% | −1.0% | −0.6% | −2.2% | −1.5% | −23.4% | −0.8% | −1.6% | 0.2% | −0.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in RXO's financial statements (latest annual report filed February 9, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
RXO financial results
In fiscal year 2025 (ended December 31, 2025), RXO reported revenue of $5.7 billion, up 26.2% from the year before. It had a net loss of $100.0 million, a net profit margin of −1.7%. Diluted earnings per share came to −$0.05. Over five years revenue grew at an average rate of 11.3% a year.
See the RXO stock overview for the latest quote and news, or the RXO chart for price history and technical indicators.
RXO income statement FAQ
What is RXO's annual revenue?
RXO reported total revenue of $5.7 billion for fiscal year 2025, which ended on December 31, 2025. That was up 26.2% from $4.5 billion the previous year.
Is RXO profitable?
No. RXO reported a net loss of $100.0 million in fiscal 2025, a net profit margin of −1.7%; its operating margin was −0.1%.
What is RXO's gross margin?
RXO's gross margin was 14.4% in fiscal 2025: for every $100 of revenue, RXO kept $14 after the direct cost of its products and services.
How fast is RXO growing?
Revenue grew 11.3% a year on average over the last five fiscal years, from $3.4 billion to $5.7 billion.
What are RXO's earnings per share?
RXO earned $-0.05 per diluted share in fiscal 2025, compared with $0.01 a year earlier.
When will RXO report its next earnings?
RXO is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens.
When does RXO's fiscal year end?
RXO's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 9, 2026.